In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that ...

Tomorrows, a global health technology company that connects patients and physicians with pre-approval treatments, today published a new data report, entitled Searching for solutions: How physicians ...

Registered by the Federal Service for Supervision of Communications, Information Technology and Mass Communications.

In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a ...

Three exercises could serve as promising alternatives to traditional insomnia treatment routes and help you sleep better, a ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug.

A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising ...

The plan – backed with a £2 billion ($2.68 billion) funding pledge – revolves around three overarching objectives; namely, ...

During a live event, Matthew Lunning, DO, and participants discussed how identifying primary refractory and early relapsed ...

As measles cases surge to record levels in the U.S., Health and Human Services Secretary Robert F. | As measles cases surge ...